Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients

BACKGROUND: Gliomas are the most frequently occurring malignant brain cancers. Recently, isocitrate dehydrogenase (IDH) mutations, O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion have been suggested to indicate a favorable prognosis in gliomas. However, the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Transl Med
Autori principali: Chen, Xi, Yan, Yuanliang, Zhou, Jianhua, Huo, Lei, Qian, Long, Zeng, Shuangshuang, Li, Zhi, Wei, Jie, Xu, Zhijie, Gong, Zhicheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6861750/
https://ncbi.nlm.nih.gov/pubmed/31807523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.09.126
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi